Emilia
Nixtaco Mexican Kitchen & Distillery, Nixtaco — Roseville, CA
California
About Emilia
Emilia is a vodka brand originating from California. The spirit is bottled at a proof level between 80 and 89, meeting standard vodka classification requirements. According to TTB records, the brand maintains one distinct product offering in the vodka category. The brand has received two label approvals from the Alcohol and Tobacco Tax and Trade Bureau, with documented registrations in 2021 and 2022. These approvals indicate the brand's presence in the spirits market during this period. As a California-origin vodka, Emilia represents the state's involvement in vodka production and distribution. The brand's registration with the TTB establishes its legal status as a commercially available spirit product in the United States market.
| Label Name | Spirit Type | Status | Approval Date | Producer | |
|---|---|---|---|---|---|
| Emilia VODKA 80-89 PROOF | Vodka 80-89 Proof | Approved | 2022-03-22 | Nixtaco Mexican Kitchen & Distillery, Nixtaco |
| Emilia VODKA 80-89 PROOF | Vodka 80-89 Proof | Expired | 2022-09-24 | Nixtaco Mexican Kitchen & Distillery, Nixtaco |
Page 1 of 1
Emilia at a Glance
Emilia has 2 distinct products with 3 total TTB label approvals, including Vodka 80-89 Proof. Labels approved between 2021-11-12 and 2022-09-24. Produced in California.
All information sourced from public TTB records.
Are you the owner or distributor of Emilia?
Claim this brand listing to update information or get featured. Contact [email protected].
Produced At
Nixtaco Mexican Kitchen & Distillery, NixtacoRelated Brands
- Hideout also from California
- New Amsterdam also from California
- Seagram's also from California
- Midtown Spirits also from California
- A1a Spirits also from California
- Muscle also makes Vodka 80-89 Proof
- Veil also makes Vodka 80-89 Proof
- Heritage Distilling CO also makes Vodka 80-89 Proof
- Svedka also makes Vodka 80-89 Proof
- Holla also makes Vodka 80-89 Proof
Related Questions
Browse All Labels
Stay informed
Newsletter coming soon.
Follow us on X for new approvals, launches, and industry intelligence.